MEDICARE PART D ENROLLEES' USE OF OUT-OF-PLAN DISCOUNTED GENERIC DRUGS, REVISITED RESPONSE

被引：2
|
作者：
Stuart, Bruce [1 ]
Loh, F. Ellen [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2013年 / 61卷 / 02期
关键词：
D O I：
10.1111/jgs.12080
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [21] Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
    Liu, Judith
    Zhang, Yuting
    Kaplan, Cameron M.
    HEALTH ECONOMICS, 2023, 32 (03) : 639 - 653
  • [22] Generic alendronate use among medicare beneficiaries: are part d data complete?
    Yun, Huifeng
    Curtis, Jeffrey R.
    Saag, Kenneth
    Kilgore, Meredith
    Muntner, Paul
    Smith, Wilson
    Matthews, Robert
    Wright, Nicole
    Morrisey, Michael A.
    Delzell, Elizabeth
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (01) : 55 - 63
  • [23] Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination
    Patel, Rajul A.
    Walberg, Mark P.
    Mai, Yvonne
    McElroy, Nataliya
    Mallya, Anil
    Kim, Aesun
    Seo, Justin
    Woelfel, Joseph A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (02) : 84 - 91
  • [24] Medicare part D plan coverage of brand-name drugs when generics are available
    Dusetzina, Stacie B.
    Cubanski, Juliette
    Nshuti, Leonce
    True, Sarah
    Hoadley, Jack
    Roberts, Andrew
    Neuman, Tricia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 304 - 304
  • [25] Clopidogrel Use Among Older Medicare Part D Enrollees after Receipt of a Drug Eluting Coronary Artery Stent
    Roth, Gregory A.
    Morden, Nancy E.
    Zhou, Weiping
    Malenka, David J.
    Skinner, Jonathan
    CIRCULATION, 2010, 122 (21)
  • [26] Regional Variation in Use of Secondary Prevention Medications among Medicare Part D Enrollees after an Acute Myocardial Infarction
    Morden, Nancy E.
    Roth, Gergory A.
    Zhou, Weiping
    Skinner, Jonathan A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S36 - S36
  • [27] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company
    Lalani, Hussain S.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 1053 - 1055
  • [28] THE EFFECT OF THE MEDICARE PART D COVERAGE GAP AND OUT-OF-POCKET BURDEN ON THE USE OF DISEASE MODIFYING DRUGS TO TREAT MULTIPLE SCLEROSIS
    Banahan, B. F., I
    Datar, M.
    Mendonca, C. M.
    Shahpurwala, Z.
    Bentley, J. P.
    Phillips, A. L.
    Stewart, M.
    VALUE IN HEALTH, 2011, 14 (03) : A211 - A211
  • [29] THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGS
    Sepulveda, B.
    Doyle, J.
    White, C.
    VALUE IN HEALTH, 2011, 14 (03) : A15 - A16
  • [30] Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis
    Hohmann, Natalie
    Hansen, Richard
    Garza, Kimberly B.
    Harris, Ilene
    Kiptanui, Zippora
    Qian, Jingjing
    VALUE IN HEALTH, 2018, 21 (10) : 1186 - 1191
12345